Literature DB >> 6727283

[Long-term observation of 15 patients with differentiated thyroid cancer and elevated plasma thyroglobulin levels of unclear origin].

H P Stumpf, M Hüfner, H J Hermann, B Kimmig.   

Abstract

The follow-up of 15 patients with differentiated cancer of the thyroid was analysed retrospectively. All patients had persistent or developed elevated thyroglobulin (Tg) plasma levels (greater than 10 ng/ml) after total thyroidectomy and 131 I therapy. There was no evidence of thyroid remnants or metastases in the 131 I whole body scan, bone scan, chest X-ray or clinical investigation. Nine of 15 patients developed local or distant metastases during a follow-up period of 3-39 months (mean = 18 months). Only one of seven recurrences tested were 131 I positive, Tg values of 9 from 12 patients showed no correlation to the Thyroid-stimulating hormone (TSH) level. It is concluded that: (1) this group of patients is at high risk of developing a recurrence (2) new methods have to be developed for the localization of 131 I negative but Tg positive metastases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6727283     DOI: 10.1007/BF01742299

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer.

Authors:  A B Schneider; B R Line; J M Goldman; J Robbins
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

2.  [Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)].

Authors:  A Jänsch; H G Heinze; B Hast
Journal:  Strahlentherapie       Date:  1981-06

3.  Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma.

Authors:  M A Charles; L E Dodson; N Waldeck; F Hofeldt; N Ghaed; R Telepak; J Ownbey; P Burstein
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

4.  Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.

Authors:  A J Herle; R P Uller
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

5.  Serum thyroglobulin in thyroid cancer.

Authors:  E G Black; A Cassoni; T M Gimlette; C L Harmer; M N Maisey; G D Oates; R Hoffenberg
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

6.  Detection of thyroid tumours using radio-labelled anti-thyroglobulin.

Authors:  D S Fairweather; A R Bradwell; S F Watson-James; P W Dykes; S Chandler; R Hoffenberg
Journal:  Clin Endocrinol (Oxf)       Date:  1983-06       Impact factor: 3.478

7.  [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms].

Authors:  M Hüfner; H Pollmann; M Grussendorf; P Schenk
Journal:  Schweiz Med Wochenschr       Date:  1980-02-02

8.  Serum thyroglobulin and recurrent thyroid cancer.

Authors:  P L Gerfo; T Stillman; D Colacchio; C Feind
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

9.  [Serum thyroglobulin estimation for follow-up of patients with thyroid carcinoma (author's transl)].

Authors:  H Botsch; E Schulz; B Lochner
Journal:  Dtsch Med Wochenschr       Date:  1979-07-27       Impact factor: 0.628

10.  The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer.

Authors:  M W Ashcraft; A J Van Herle
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

View more
  1 in total

1.  [Surgery of metastases of differentiated thyroid cancers].

Authors:  H D Röher; P E Goretzki; R A Wahl
Journal:  Langenbecks Arch Chir       Date:  1987
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.